Glucose Meters

Conductive Technologies Inc. (CTI) is a contract manufacturer specializing in printed electronics and biosensors for the medical device and industrial markets. Founded in 1970 and based in York, Pennsylvania, CTI operates a 110,000 sq. ft. facility with approximately 61 employees and generates $15.4 million in annual revenue. The company holds FDA compliance and ISO 13485 (medical devices) and ISO 9001 certifications, supporting full medical device project development from conception through FDA clearance. CTI's core competencies include electrochemical sensors, biosensors, flexible circuits, and membrane switches. The company manufactures disposable glucose test strips, multiplexed point-of-care diagnostic sensors, wearable devices, and biochips/microfluidics. Manufacturing capabilities include precision laser ablation, fine-line screen printing, and flexible printed circuitry with diverse inks and materials. CTI offers design innovation, development services, and post-commercialization collaboration, particularly for next-generation disposable diagnostic biosensors and Phase Zero Sensors for early-stage biochemical assay development. The structured development process ensures products meet customer requirements and market competitiveness.

Founded in California in 2017, Kerae Medical Inc. is a manufacturer-direct distributor and retailer of medical supplies and equipment serving hospitals, healthcare facilities, and individuals. The company specializes in incontinence supplies (adult diapers, underpads, perineal care products), comprehensive wound care solutions (dressings, bandages, gauze, tape, ointments), and infection control products (gloves, masks, isolation gowns, PPE). Additionally, Kerae Medical supplies durable medical equipment including hospital beds, mattresses, mobility aids (wheelchairs, walkers, canes), bathroom safety equipment (shower chairs, commodes, raised toilets), respiratory devices (CPAP, BiPAP, oxygen therapy, nebulizers), and diagnostic/screening tools (blood glucose monitors, blood pressure monitors, pulse oximeters, thermometers, stethoscopes). The company offers direct-to-facility pricing, dedicated account management for institutional customers, clinical consultation services, and rapid nationwide shipping. As the original brand owner of its products, Kerae Medical emphasizes quality sourcing, regulatory compliance, and responsive customer service to both home care and facility-based healthcare providers.

FondCircle is a digital health company providing smart, connected home health monitoring devices and a telehealth platform. The company offers a range of FDA-cleared or regulated medical devices including Bluetooth-enabled blood pressure monitors (upper arm and wrist), pulse oximeters, blood glucose meters, infrared thermometers, and smart body composition scales. All devices sync with the FondCircle mobile app (iOS/Android), enabling users to track health metrics, review trends, and share data with healthcare providers. The platform also facilitates practitioner listings and remote consultations. FondCircle targets consumers, families, and health systems seeking accessible, accurate at-home monitoring and hospital-level telehealth services without frequent clinic visits.

Medtronic is a global healthcare technology leader serving 79+ million patients across diagnostic imaging, surgical and operating room equipment, intensive care, specialty medical, and homecare sectors. The company manufactures and distributes a comprehensive portfolio spanning cardiac rhythm and diagnostics systems, pacemakers, implantable cardioverter-defibrillators, deep brain stimulation devices, robotic surgery platforms, ventilators, anesthesia machines, infusion pumps, continuous glucose monitoring systems, insulin pumps, endoscopic and surgical navigation systems, and wound closure products. Recent FDA clearances include the Stealth AXiS surgical system for spine surgery and pulsed field ablation (PFA) technologies for atrial fibrillation treatment. Medtronic serves hospitals, surgical centers, critical care units, interventional labs, and home care settings through product lines in cardiac, vascular, neuromodulation, minimally invasive surgery, respiratory, and diabetes management. The company conducts 170+ active clinical trials, invests $2.7B annually in R&D, and holds FDA 510(k) clearances, CE marks, and ISO 13485 certification. Manufacturing and distribution capabilities span North America, Europe, and international markets with customer support available 24/7.

CorDx Labs is a biotechnology company specializing in in vitro diagnostic (IVD) products for point-of-care and over-the-counter use. With 18+ years of industry experience, CorDx operates a vertically integrated supply chain with manufacturing facilities across the United States and internationally, serving 170+ countries through a global network of 700+ partners. The company manufactures and distributes a portfolio of 1,000+ diagnostic products spanning infectious disease testing (including multiplex rapid tests for flu, COVID-19, and RSV), reproductive and fertility testing, molecular diagnostics, and pet diagnostics. CorDx also offers contract manufacturing services for diagnostic products across multiple therapeutic areas, leveraging advanced quality and compliance systems to ensure operational excellence.

Hearts Bio is a California-based medical device and wellness company offering an integrated ecosystem for health management through diet, fitness, and self-monitoring. The HeartsCare product line comprises portable, Bluetooth-enabled diagnostic meters for at-home testing of cholesterol, glucose, lactate, and ketone levels—each with rapid results and data logging capabilities. HeartsFit provides fitness equipment including performance bicycles. HeartsDiet supplies food weighing scales for dietary tracking. The company also develops HeartsHome, a 3D mobile application (iOS/Android) that aggregates health metrics and test results in an interactive dashboard. HeartsCubeAI represents precision medicine and genomic AI in development. Hearts Bio targets individuals managing chronic disease risk factors (heart disease, diabetes, cancer) and fitness-focused consumers seeking integrated home health monitoring and lifestyle management tools.

Anriwell is a medical-grade home health monitoring platform specializing in connected devices and ecosystem solutions for elderly care and family wellness. The company manufactures FDA-cleared and MDR-certified vital sign monitoring devices including blood pressure monitors, glucose meters, pulse oximeters, infrared thermometers, and intelligent sleep monitors. All devices integrate with the Anriwell App, which centralizes health data tracking, family sharing, and remote monitoring capabilities. Beyond hardware, Anriwell Home provides smart home safety features (fall detection, water/gas sensors) designed to enable independent living for seniors. The ecosystem is positioned for multi-generational caregiving, enabling remote family members to monitor loved ones' health trends and receive alerts for early intervention.

Outsource Pharmacy Solutions is a comprehensive medical supplies distributor offering an extensive catalog of consumables, home care products, mobility aids, and patient care equipment. The company supplies diabetes care products (glucose meters, lancets, test strips), incontinence management solutions (briefs, protective wear, underpads), enteral nutrition supplies (feeding tubes, pumps, nutritional drinks), wound care (dressings, gauze, bandages), PPE (masks, gloves, isolation gowns), mobility devices (wheelchairs, walkers, crutches), home monitoring equipment (blood pressure monitors, oximeters, scales), and rehabilitation aids (compression therapy, TENS devices). Additionally, the company stocks hospital furniture, patient room supplies, janitorial products, and first aid kits. The platform operates with FSA/HSA payment options and a loyalty rewards program, serving healthcare facilities, clinics, and individual consumers.

Nova Biomedical is a privately held, globally-leading in vitro diagnostic (IVD) company founded in 1976 and headquartered in Waltham, Massachusetts. The largest privately owned diagnostic company in the United States, Nova Biomedical employs over 1,500 people across manufacturing facilities in Massachusetts and Taipei, Taiwan, serving 110+ countries through its global distributor network. The company specializes in advanced blood testing and analytical instrumentation, with a comprehensive portfolio including critical care blood gas analyzers (StatProfile® Prime series), point-of-care glucose meters (StatStrip®, NovaMax®), cell culture analyzers (BioProfile® Flex), clinical and bioprocessing osmometers, liquid volume verification systems, and automated CSF cell counters. Nova Biomedical serves hospitals, emergency departments, blood banks, biotech/pharmaceutical manufacturers, clinical research laboratories, and veterinary diagnostics markets. The company operates through multiple trusted brand portfolios including Advanced Instruments, BioProfile, StatProfile, StatStrip, Artel, Solentim, and GloCyte, delivering solutions for bioprocessing, clinical diagnostics, and veterinary applications with emphasis on improving patient outcomes and operational efficiency.

Arpovo Health is a B2B medical supplies distributor offering a comprehensive catalog of trusted medical consumables and homecare products. The company specializes in insulin syringes (SOL-M, EasyTouch, AIMSCO brands) with multiple needle gauges and safety features, hypodermic needles, IV therapy supplies including intravenous adapters and components, glucose test strips for diabetes management, personal protective equipment (nitrile exam gloves, 3-layer face masks), and diagnostic instruments. Products feature quality brands including MHC Medical, Delta Hi-Tech, B. Braun, Hospira, and Ansell. Arpovo Health emphasizes secure shipping, quality assurance, and 24/7 customer support, positioning itself as a reliable source for healthcare facilities, clinics, and individual users requiring consistent access to medical consumables and diabetes management supplies.

ABOUND Diagnostics, Inc. is a San Diego-based in vitro diagnostic (IVD) manufacturer specializing in rapid diagnostic tests and point-of-care testing (POCT) products for both human and veterinary health markets. The company offers a comprehensive portfolio including rapid tests for women's health, drugs of abuse, infectious diseases, tumor markers, and cardiac markers; blood glucose monitoring systems (VivaGuard® Ino, VQ PET H); lancing devices and lancets; infrared thermometers; urinalysis and biochemistry reagent strips; and fluorescence immunoassay (FIA) and chemiluminescence immunoassay (CLIA) test kits. ABOUND serves US and international markets, with a mission to deliver high-quality, affordable diagnostic solutions that improve healthcare access globally.

KetoBM USA LLC manufactures and distributes the KetoBM Blood Ketone Meter, a complete ketosis testing kit designed for individuals following ketogenic diets. The product includes a portable ketone meter, lancing device, lancets, and test strips for measuring blood ketone levels (mmol/L). The company provides educational resources on ketone result interpretation and ketogenic lifestyle guidance. KetoBM meters are designed for home use and measure ketone levels to help users monitor nutritional ketosis, with optimal ranges typically between 1.0–2.0 mmol/L. The device is marketed as simple, accurate, and affordable for personal metabolic monitoring.

MyCareTeam develops MCT-Diabetes, a comprehensive diabetes monitoring and management platform designed to improve health outcomes and reduce overall healthcare costs. The solution facilitates communication and real-time monitoring between patients, caregivers, and healthcare professionals, enabling better disease management between clinical visits. MCT-Diabetes is marketed to three primary user groups: family caregivers seeking to support loved ones with diabetes regardless of location; healthcare professionals aiming to enhance patient quality of life through inter-visit monitoring and engagement; and organizations incorporating diabetes management into corporate wellness and employee health programs. The platform is offered on flexible monthly and yearly subscription models, making it accessible for individual and enterprise-level adoption.

US Diagnostics, Inc. is a medical equipment manufacturer specializing in blood glucose monitoring systems and diabetes management solutions. The company develops and distributes FDA-approved glucose meters and test strips designed for patient self-monitoring. Their product line, including the INFINITY® Blood Glucose Monitoring System, features biosensor technology with capillary action for rapid results, automatic coding, small sample volume requirements, and user-friendly interfaces. US Diagnostics focuses on providing accurate, affordable diabetes supplies with clinical accuracy and easy-to-use designs. The company serves patients and healthcare providers through expanded distribution networks and partnerships, offering comprehensive patient education and control solutions for diabetes management.

Yuwell Medtech USA LLC is a global leader in home healthcare medical devices and chronic disease management solutions. Founded in 1998 in Danyang, China, and headquartered in Shanghai, Yuwell became the first privately owned medical device company listed on a Mainland Chinese stock exchange in 2008. The company operates as a diversified healthcare conglomerate with over 80 holding companies and maintains 12 R&D centers and 9 production bases across China and Europe. Yuwell serves more than 300,000 medical institutions across 131 countries, reaching approximately 300 million households worldwide. The company specializes in respiratory therapy devices, diabetes management and monitoring solutions, patient vital signs monitoring (blood pressure, temperature, blood oxygen), rehabilitation equipment, emergency response systems, infection control products, and ophthalmic diagnostics. Recognized as the #1 brand in China for multiple product lines, Yuwell aims to rank among the top three home healthcare medical device groups globally by 2028, driven by technology innovation and commitment to improving healthcare accessibility and affordability.

Princeton BioMeditech Corporation (PBM) is a world leader in rapid, point-of-care diagnostic products. The company manufactures and distributes an extensive portfolio of over 70 different one-step rapid diagnostic tests utilizing patented immunoassay technologies. PBM serves both consumer in-home and professional on-site/point-of-care markets with FDA-cleared and ISO 13485:2016 certified products. Product lines include rapid antigen detection tests for COVID-19/Flu, cardiac markers, infectious disease diagnostics, fertility testing, drugs of abuse screening, tumor markers, and food/environmental pathogen detection. The company offers OEM services, point-of-care analyzer systems, research and development capabilities, and comprehensive product support. Based in Princeton, New Jersey, PBM maintains USA manufacturing operations and serves healthcare providers, clinical laboratories, and consumers globally.

Blue Echo Care is a family-owned and operated medical device retailer based in Portland, Oregon, providing high-quality home healthcare products at affordable prices. The company supplies clinical-grade medical instruments and devices comparable to those found in doctor's offices and medical facilities, directly to consumers. Their product portfolio includes CPAP machines and masks for sleep apnea management, pulse oximeters, portable ECG monitors, nebulizers and accessories, hearing aids, ear health instruments, blood glucose meters and testing strips, compression leg massagers, wellness kits containing masks and sanitizers, and other diagnostic and monitoring devices. All products undergo rigorous clinical testing to ensure quality and durability. Blue Echo Care operates a 24/7 American customer service team and offers free shipping within the continental US for most products. The company also maintains a community commitment program, donating personal protective equipment and hand sanitizers to healthcare facilities in need with each wellness kit purchase.

Sinocare Inc. is a leading global biosensing technology company specializing in rapid diagnostic test products for chronic disease management, particularly diabetes. Founded in 2002 and headquartered in Changsha, Hunan Province, China, the company ranks #1 in blood glucose meter (BGM) markets in China and #4 worldwide, serving over 25 million users across 187 countries and regions. Sinocare went public in 2011 with 2022 revenues of approximately $248 million. The company develops and manufactures a comprehensive product portfolio including blood glucose meters, test strips, continuous glucose monitoring (CGM) systems, blood pressure monitors, and multiparameter diagnostic devices. Additionally, Sinocare provides hospital diabetes management systems and integrated digital health solutions combining biosensing technology with smart healthcare platforms. With 9 global R&D and manufacturing sites, the company has established substantial international presence through strategic acquisitions including Nipro Diagnostic Inc. and PTS Diagnostics Inc., positioning itself as a comprehensive chronic disease management solution provider for both individual patients and healthcare institutions.

Northeast Medical Products is a BOC-accredited durable medical equipment and home healthcare supplies provider based in Old Saybrook, Connecticut, with over 45 years of industry experience. The company specializes in a comprehensive range of medical supplies including mobility aids, orthopedic solutions, hospital beds, lift chairs, incontinence products, ostomy supplies, wound care materials, women's health products, sleep therapy equipment, and diabetic care supplies. Their certified professional team assembles, fits, and prepares equipment for immediate use. Northeast Medical accepts multiple insurance plans including Medicare, Medicaid, Blue Cross Anthem, United Healthcare, and Oxford. The company operates as a retail and home delivery supplier, serving patients, caregivers, and healthcare providers throughout New England with a customer-first approach and emphasis on product quality and reliability.

HealthArc is a comprehensive digital health platform specializing in remote patient monitoring (RPM), chronic care management (CCM), and care coordination software for healthcare providers. The platform integrates with over 40 compatible medical devices (blood pressure monitors, glucometers, pulse oximeters, weight scales, spirometers, continuous glucose monitors, thermometers, and medication adherence trackers) to enable real-time vital sign monitoring and patient data collection. HealthArc's unified care platform features AI-driven clinical pathways, automated workflow management, and intelligent patient communication via SMS and phone escalation. The software supports multiple CMS-compliant care programs including Remote Patient Monitoring, Chronic Care Management, Principal Care Management, Remote Therapeutic Monitoring, Transitional Care Management, Medication Therapy Management, Behavioral Health Integration, and Advanced Primary Care Management. The platform automates billing documentation and claims submission across these programs, integrates with existing EHR systems, and includes specialized clinical support services with enrollment specialists, RNs, LPNs, and medical assistants. HealthArc serves hospitals, primary care practices, virtual care delivery companies, and managed healthcare organizations, with current deployment across 40+ states serving 750+ providers and 65,000+ patients. The company prioritizes HIPAA compliance, SOC2 certification, and FDA-approved device integration.

Bionime Corporation is a Taiwan-based medical device manufacturer (founded 2003, publicly listed 2007) specializing in blood glucose management systems for personal and professional use. The company designs, manufactures, and markets Blood Glucose Meters (BGM), Continuous Glucose Monitoring (CGM) systems, Point-of-Care Testing (POCT) devices, and related consumables including test strips and lancing devices. Bionime has developed a proprietary cloud-based ecosystem branded RIGHTEST, utilizing IoT-enabled digital solutions to integrate product data with customer service and market intelligence for comprehensive diabetes management. With 480+ core CGM patents, Industry 4.0 manufacturing capabilities, and self-built software integration, Bionime operates globally through subsidiaries in Australia and Shenzhen, distributing to United States, Europe, and multiple international markets. The company targets both individual patients and healthcare institutions, positioning affordable, high-quality blood glucose control solutions to prevent diabetes-related complications.

Concord Health Supply, Inc. is a family-owned, worldwide distributor of pulse oximeters, blood pressure monitors, EKG devices, and complementary home and clinical health care products. Based in Skokie, Illinois, the company is the #1 retailer of USA-made Nonin pulse oximeters and an authorized distributor of Nonin, Masimo, ChoiceMMed, and Contec brands. Serving individuals, physician offices, nursing homes, EMS providers, sleep labs, and medical centers, Concord emphasizes same-day shipping, competitive pricing, and a 100% satisfaction guarantee with 30-day returns/exchanges. The company maintains a 4.9/5.0 Amazon rating with over 12,000 positive reviews, demonstrating strong B2B and B2C market presence in remote patient monitoring and wellness products.

VivaChek Diagnostics, Inc. is a Sacramento, CA-based subsidiary of VivaChek Biotech, a global point-of-care testing (POCT) manufacturer established in 2013. The company specializes in blood glucose monitoring systems, drugs-of-abuse testing solutions, and related diagnostic devices. VivaChek operates globally across 120+ countries, offering OEM, ODM, and manufacturing services. Product lines include FDA-cleared blood glucose meters (including the VivaChek Link Plus 4G system with advanced FAD enzyme technology), multi-drug urine test cups, fentanyl-specific FIA test kits, and the BioSieve Toxismart FIA Reader platform. Recent FDA clearances include: three glucose meters (2024), BioSieve Fentanyl FIA Home Test Kit and Reader for OTC use (2024), VivaChek Link Plus 4G (2023), and Multi-Drug Urine Test Cup (2023). The company also manufactures lactate analyzers and multifunction monitoring systems. VivaChek maintains FDA 510(k) clearances and demonstrates commitment to quality and innovation through participation in major medical trade shows (Medica, FIME). The company serves workplace drug testing, clinical diagnostics, and home health monitoring markets.

Sejoy is a high-tech medical device manufacturer founded in 2002, specializing in home-care electronic medical products and point-of-care diagnostic systems. The company designs, develops, manufactures, and markets a comprehensive portfolio of monitoring and testing devices including blood glucose monitoring systems, lipid panel analyzers, hemoglobin monitoring systems, uric acid monitoring systems, urine analysis systems, infectious disease testing platforms, drug-of-abuse testing solutions, and fertility testing systems. All products are manufactured under ISO 13485 quality management standards and hold regulatory certifications including FDA approval, CE marking (European), RoHS, REACH, MDSAP, and FCC compliance. Sejoy operates three major technology research and development platforms: electromechanical, optoelectronic, and biochemical. The company maintains a strong R&D team with over 80% of staff holding bachelor's or master's degrees. Manufacturing capabilities include full quality control protocols (IQC, IPQC, FQC, OQC) with 100% pre-shipment inspection. The company offers OEM/ODM services for customization of color, packaging, user manuals, and functional design modifications. Warranty coverage includes one year of complimentary service with lifetime after-sales support. Sejoy serves global markets with a focus on cost-effective, clinically validated diagnostic instruments suitable for clinical laboratories, point-of-care facilities, and home health monitoring applications.

Genteel, LLC manufactures pain-free lancing devices for blood glucose monitoring. The company specializes in innovative, vacuum-assisted lancing technology designed to minimize discomfort during capillary blood sampling. Core products include the Genteel Basic and Genteel Exclusive lancing devices, which feature customizable depth control via colored contact tips and are engineered to reduce nerve-related pain sensations. The company also produces proprietary Butterfly Touch Lancets with beveled tips (30–36 gauge) formulated to minimize tissue irritation. Replacement parts including nozzles, contact tips, and o-rings are available for device maintenance. Products are marketed to Type 1 and Type 2 diabetics, gestational diabetes patients, and continuous glucose monitor (CGM) users. Genteel emphasizes U.S. manufacturing, offering a 30-day money-back guarantee and 1-year manufacturer warranty on lancing devices. The company provides customer support via phone and email, with same-day order shipment and extended product durability (customer reports of 10+ years of use). Devices are clinically proven to reduce testing pain, increase testing frequency, and improve A1C outcomes. No FDA or CE certifications are explicitly stated on the website.

Omnis Health LLC manufactures and distributes the Embrace® portfolio of affordable, high-quality blood glucose testing products for diabetes management. The product line includes blood glucose meters (EmbracePRO, EmbraceTALK, EmbraceWAVE+), test strips, lancing devices, lancets, and control solutions. Designed for cash-pay and Medicare patients, Embrace products emphasize ease of use, accuracy, and cost-effectiveness to support better diabetes monitoring and management. The company offers no-coding meters with features such as audible instructions, Bluetooth connectivity, large displays, fast results (as little as six seconds), and memory storage of up to 500 test results. Products are distributed through multiple retail channels, mail service providers, and online platforms including Amazon.

Oxiline LLC manufactures medical-grade personal health monitoring and therapeutic devices for home use. The company integrates clinical-precision sensors into consumer-friendly personal devices, bridging the gap between professional-grade accuracy and home accessibility. Primary product lines include the Pressure XS Pro (FDA-cleared blood pressure monitor with app integration and HSA/FSA eligibility), Gluco XS Pro (smart blood glucose meter kit), Pulse XS Pro (SpO₂ and pulse rate monitor), Hear XS Pro (premium Bluetooth hearing aid), Tens XS Pro (TENS/EMS unit for pain relief and muscle performance), Scale MD Pro (smart scale with body composition and segmental analysis), and Therma Series thermometers. All devices feature app connectivity for centralized health tracking and data sharing with healthcare providers. Products carry lifetime warranty, 30-day money-back guarantee, and same-day expedited shipping. The company has extensive media coverage and endorsements from healthcare professionals and professional athletes. Certifications include FDA clearance for blood pressure and glucose monitoring devices. Target markets include consumers managing chronic conditions, fitness athletes, and healthcare-conscious individuals seeking at-home clinical-grade monitoring.

BIO-MED HEALTHCARE PRODUCTS PVT is an India-based medical device manufacturer and distributor specializing in consumables, diagnostic equipment, and respiratory/therapeutic devices. The company markets seven primary product lines: Infusion Therapy (IV cannulas, catheter sets, scalp vein sets), Respiratory Devices (breathing support and pulmonary function tools including lung exercisers), Diabetic Products (glucose monitoring and management supplies), Haemodialysis (dialysis consumables and accessories), Urology (urological catheters and devices), Electrocardiography (ECG systems and monitoring equipment), and Surgery (surgical instruments and supplies). The company serves hospitals, clinics, and healthcare facilities across India and international markets, with documented participation in major medical trade exhibitions including Arab Health, Medica, IPHEX, and FIME. BIO-MED positions itself as a quality-focused manufacturer emphasizing regulatory compliance and healthcare innovation. The product portfolio spans both single-use consumables and reusable medical devices, with particular strength in infusion therapy and respiratory care. The company maintains technical documentation and downloadable product catalogs, indicating B2B-oriented sales operations. No specific FDA, CE, or ISO certifications are explicitly stated on the homepage, though participation in international exhibitions suggests compliance with relevant regulatory frameworks.

American Hospital Supply is a family-owned B2B and B2C medical supplies distributor based in Santa Monica, California. The company provides comprehensive medical products including PPE, wound care supplies, mobility aids (walkers, rollators), incontinence supplies, surgical instruments, diagnostic equipment, AEDs with accessories, bleed control kits, clinical accessories, and training/educational products. AHS serves hospitals, clinics, schools, community centers, and individual consumers. The company emphasizes quality standards, expert product knowledge, timely shipments, and 24/7 customer support. AHS offers free shipping on orders $99+, accepts HSA/FSA and purchase orders, and maintains a private-label product line (AHS Brand) with Prime eligibility. The company is FDA-registered and holds California DGS SBE Certification.

Biolinq Incorporated develops continuous glucose monitoring systems for personal health management. The company's flagship product, Biolinq Shine™, is a needle-free, fully autonomous glucose sensor that measures and displays real-time glucose levels through an integrated color-changing LED light indicator (blue for target range, yellow for above-range glucose). The device integrates glucose monitoring with activity tracking and sleep monitoring via built-in accelerometer and ambient light sensors, eliminating the need for separate wearables. Biolinq Shine™ is FDA-cleared for use in persons 22 years or older not on insulin therapy and is intended to support glycemic control management through behavior and lifestyle modifications. The accompanying mobile application provides granular glucose analysis, correlates readings with meals, rest, and activity patterns, and delivers personalized insights to support trend tracking and health goal management. The device qualifies as a personal medical device for home and continuous use, targeting individuals managing non-insulin-dependent diabetes or pre-diabetes. Biolinq has secured substantial venture capital funding from prominent healthcare and investment firms, indicating commercial-stage development and market launch readiness.

LifeScan is a global leader in glucose monitoring and diabetes management, serving more than 20 million consumers worldwide through its OneTouch® brand. The company develops and markets blood glucose meters, continuous glucose monitoring systems, mobile applications, and related digital health solutions for diabetes self-management. Product lines include the OneTouch Verio Flex® blood glucose meter paired with the OneTouch Reveal® mobile application, which provides real-world evidence of improved glycemic control. LifeScan recently announced a transformational partnership with i-SENS to launch a OneTouch® Continuous Glucose Monitoring System, expanding its portfolio into CGM technology. The company emphasizes patient-centric digital solutions and clinical validation; multiple peer-reviewed studies document clinically significant improvements in glycemic control across diverse patient populations using LifeScan's smart meters and mobile apps. LifeScan serves both individual consumers and healthcare systems, with a focus on Type 1 and Type 2 diabetes management. The company maintains a global presence and was recently recognized by the Princess Royal Training Awards (2024). Operations include manufacturing, digital partnerships, customer support, and clinical research capabilities. LifeScan emerged from financial restructuring in 2025 with renewed operational focus on innovation and market expansion.

IJDream Corporation manufactures and distributes the Oh'Care Lite blood glucose monitoring system, a home-use diagnostic device designed for diabetes self-management. The product line includes the Oh'Care Lite Glucose Meter with auto-coding functionality, test strips featuring latest biosensor technology, lancets with five depth settings and pain-reduction design, and control solution for quality assurance testing. The company positions itself on affordability and accessibility, offering bundled kits combining the meter, test strips (50–200 count), lancets (100–200 count), control solution, lancing device, and luxury carry case with 3-year warranty and 30-day money-back guarantee. Key product features include 365-result memory, automatic test alerts, hygienic auto-eject function, and compliance with ISO-15197:2013 standardization with documented lab and clinical efficacy testing. Market focus is on individual consumers and households managing diabetes, emphasizing ease of use and lower cost relative to branded competitors. The company sells directly to end-users through e-commerce with consumable refills (test strips, lancets, control solution) available in multiple bundle configurations.

Smart Meter LLC is a leading remote patient monitoring (RPM) technology and solutions provider headquartered in Tampa, Florida. The company specializes in cellular-enabled personal health monitoring devices and cloud-based platforms designed for RPM and chronic care management (CCM) programs. Smart Meter manufactures and distributes FDA-approved, multi-carrier SIM cellular devices including glucose monitors (iGlucose Plus), blood pressure monitors (iBloodPressure, iBP Classic), pulse oximeters (iPulseOx), and weight scales (iScale). All devices transmit readings directly via 4G/5G cellular networks with no hub, Bluetooth pairing, or WiFi required. The company operates a proprietary private data network developed in collaboration with AT&T, providing multiple layers of HIPAA-compliant data security. Smart Meter's platform includes patient engagement tools (Smart Touch®), comprehensive data analytics dashboards, device management portals, and performance reporting. The company manages over 315,000 patients for 800+ RPM partners including healthcare providers, RPM platforms, and software integrators. Additional services include world-class logistics with same-day shipping for orders placed by 1 PM ET, Tier 1/Tier 2 technical support, and dedicated client success management. Regulatory compliance includes FDA approval, HIPAA, FTC, Medicare, and commercial payor requirements. The company processes 3+ billion data points annually and ships 1+ million orders annually.

Remote Patient Devices, LLC is a US-based remote patient monitoring (RPM) provider serving medical practices, healthcare facilities, and chronic disease management programs. The company develops and operates a cloud-based RPM platform enabling patients to transmit vital signs—blood pressure, glucose levels, and weight—from home or office settings for real-time clinical review. The platform integrates with existing EHR systems, supports iOS and Android mobile applications, and includes automated time tracking, customizable clinical alerts, and EMR interoperability. Remote Patient Devices serves solo practices, group practices, and larger healthcare systems seeking to expand preventive and chronic care management outside traditional clinical settings. The company handles end-to-end RPM implementation including patient eligibility verification, care plan development, medical billing and coding, and compliance with current healthcare regulations (MIPS quality measures, value-based care models). The platform emphasizes patient engagement, clinical actionability of real-time data, and revenue optimization through accurate remote patient monitoring billing. Core use cases include hypertension management, diabetes monitoring, and post-acute care transitions. Remote Patient Devices markets RPM as a tool for reducing hospital readmissions, improving MIPS scores, and generating $100,000–$150,000 annual revenue per 100 monitored patients for practices. The company provides practitioner training, ongoing clinical support, and billing assistance to ensure sustainable adoption.

Osang Healthcare is a South Korean diagnostic manufacturer with 25+ years of global experience operating in 110+ countries. The company specializes in rapid infectious disease testing and point-of-care diagnostics for healthcare providers, laboratories, and community settings. Core product portfolio includes COVID-19 and flu antigen rapid tests, COVID-19 PCR testing solutions, and point-of-care blood glucose monitors for human and veterinary use. The company has deployed over 20 million COVID-19 PCR tests across 70+ countries and supplied 130 million rapid antigen tests in the US market. Osang holds FDA Emergency Use Authorization (EUA) credentials and was the first South Korean company to receive FDA authorization for SARS-CoV-2 test kits. Quality certifications include ISO 9001, ISO 13485, TÜV SÜD, and MDSAP compliance. Manufacturing operations include GMP-certified facilities in Korea. The US subsidiary, Osang LLC, is based in South Pasadena, California, providing dedicated account management, logistics support, and technical assistance for healthcare partners nationwide. The company markets solutions for rapid turnaround, scalable deployment, and reliability in clinical and emergency settings.

Bosung Meditech Co., Ltd manufactures SafeLan, a premium lancing device and lancet system designed for safe, painless daily diabetes management. The product features an innovative all-in-one design with a concealed needle mechanism that eliminates accidental needlestick injuries and prevents cross-contamination through single-use lancets. The SafeLan system combines patented double-spring technology with adjustable depth settings (1-5 steps) to minimize skin damage and user pain during blood sampling. The protective tip and cap design ensures the needle remains hidden at all times, reducing visual anxiety and improving user compliance. Marketed for both hospital and home use, SafeLan addresses critical safety concerns in blood glucose monitoring while maintaining ease of use with a simple four-step operation. Products are available through Amazon and direct B2B channels.

Life Extension is a science-based nutritional supplement and wellness company founded in 1980, headquartered in Fort Lauderdale, Florida. The company specializes in pharmaceutical-grade vitamins, minerals, herbal extracts, and targeted formulations designed to support longevity, healthy aging, and disease prevention. Product lines include NAD+ supplements for cellular energy, mitochondrial support formulas, cognitive health nutrients (including Neuro-Mag® Magnesium L-Threonate), omega-3 fish oil blends, and stress-management supplements. Life Extension also offers direct-to-consumer blood screening services, enabling customers to access advanced laboratory tests without prescriptions. The company publishes Life Extension Magazine and the Disease Prevention and Treatment textbook series, providing evidence-based health guidance. With approximately 500 employees, Life Extension maintains a retail presence and invests heavily in clinical research and scientific validation of its formulations, positioning itself as a leader in the preventive medicine and longevity supplement space.

Simple Diagnostics is a supplier of home diagnostic and diabetes care consumables serving the United States and international markets. The company specializes in blood glucose monitoring systems, blood pressure monitors, insulin delivery devices, and lancing equipment for diabetes self-management. Product portfolio includes: blood glucose monitors with features such as bilingual voice guidance and easy-to-read displays; wrist and automatic blood pressure monitors with WHO indicators; insulin pen needles in multiple gauges compatible with all major diabetes pens sold in the US; insulin syringes in standard sizes; lancing devices and lancets; alcohol prep pads; and inhaler chambers for respiratory care. The company also offers a veterinary supply line. Simple Diagnostics holds FDA clearance and CE certification for its products. The organization operates regional sales channels for Latin America, Africa, the Middle East (Dubai office), and international markets. Products are designed with emphasis on accuracy, safety features (including irregular heartbeat warnings), and cost-effectiveness for patient home use. The company serves both individual consumers and professional/dealer channels.

Artheon Medical is a US-based durable medical equipment (DME) provider specializing in Continuous Glucose Monitors (CGMs), external catheters, and compression orthotics. The company serves patients requiring ongoing glucose monitoring and urinary management solutions, with established partnerships with major manufacturers including Abbott, Dexcom, and BD. Products include CGM systems (Dexcom, FreeStyle Libre, Medtronic), PureWick external urine collection systems, and compression orthotic devices (AMP FreedomX, EZrap, EZshield). Artheon operates as a Medicare and Department of Labor-authorized supplier, managing insurance verification and patient enrollment. The company emphasizes direct-to-patient delivery with free shipping, US-based customer support, and coordination with physician referrals. All products are from FDA-cleared manufacturers and meet standard medical device regulations. Distribution model focuses on DME supply chain integration and white-glove service for chronic disease management.

Core Technology Co., Ltd. is a subsidiary of CorDx Union, an international medical diagnostics group established in 2006. The company specializes in in vitro diagnostic (IVD) test kits and point-of-care (POC) testing solutions, serving over 120 countries with more than 1 billion users globally. Product portfolio includes fertility tests, respiratory infectious disease diagnostics, sexual transmitted disease screening, infectious disease panels, cardiac markers, tumor markers, drug-of-abuse screening, and health monitoring tests including blood glucose measurement systems. The company maintains FDA, CE (Conformité Européenne), and NMPA (National Medical Products Administration, China) regulatory certifications for its diagnostic products. Core Technology operates R&D centers, manufacturing facilities, and sales platforms across the United States (California and Georgia headquarters), United Kingdom, Dubai, and Singapore. Manufacturing and quality capabilities are centered in Beijing with industrial facilities exceeding 100,000 square meters. The company participates in major international medical trade shows including Medica, Medlab Asia, and Hospitalar, indicating active engagement in the global clinical diagnostics market.

J&B Medical is a family-owned healthcare supplier founded in 1996, operating as a recognized market leader in medical consumables, devices, and support services. The company distributes insurance-covered medical supplies, emergency first responder supplies, medical and surgical supplies, homecare products, and veterinary medical supplies. Primary product focus includes incontinence supplies (particularly through state insurance programs), diabetic management supplies (insulin pumps, continuous glucose monitors such as Dexcom6 and OmniPod5), and general medical/surgical consumables. J&B Medical operates multiple complementary business units: an insurance member portal for ordering and account management, emergency medical supply distribution (EMS), medical and surgical supply retail, telehealth services via affiliated HNC Virtual Solutions, and a veterinary supply division (J&B Pet Source). The company emphasizes customer service with insurance verification assistance, order tracking, prescription coordination with healthcare providers, and rapid fulfillment. Services include sole source program management, national managed care contracts, and technology solutions. J&B Medical serves individual consumers, insurance members, emergency responders, and healthcare facilities across the United States, with demonstrated expertise in managing complex insurance authorizations and fulfillment logistics.

Gluco Perfect is a manufacturer of blood glucose monitoring systems for self-monitoring of blood glucose levels in diabetic patients. The company provides accurate, affordable, and minimally invasive in vitro diagnostic solutions for daily glucose testing. Gluco Perfect offers high-quality glucose meters and related products with emphasis on responsive customer service and product reliability for the global diabetic community.

Cliawaived, Inc. is a CLIA-waived medical testing and diagnostic supplies distributor serving clinical labs, physician offices, and home-use markets. The company supplies a broad range of point-of-care (POC) testing products including rapid drug screening tests (drug test cards and cups), infectious disease diagnostics (COVID-19, flu, RSV, mono, strep testing), STD/sexual health testing kits, urinalysis consumables, women's health tests, and general medical supplies. Product portfolio includes analyzers and meter devices (glucose monitors and similar POC analyzers), distributed under partnerships with established manufacturers such as Quidel. The company operates an e-commerce platform enabling B2B procurement of CLIA-waived test kits and supplies for clinical settings and direct-to-consumer home testing products. As a distributor of CLIA-waived diagnostics, Cliawaived serves urgent care centers, physician offices, occupational health programs (workplace drug screening), clinical laboratories, and patients seeking over-the-counter diagnostic testing. All products are CLIA-waived, meeting regulatory thresholds for simple test methodology and low clinical risk. The company maintains inventory of consumables and point-of-care instrumentation to support rapid deployment and same/next-day fulfillment for high-volume testing operations.

Harvard Bioscience Inc is a holding company and distributor of laboratory and research equipment serving academic institutions, contract research organizations (CROs), pharmaceutical, and biotech companies. The company operates through multiple subsidiary brands including Data Sciences International (DSI), BTX Electroporation Systems, Multi Channel Systems (MCS), Biochrom, HEKA, Harvard Apparatus, Panlab, Warner Instruments, CMA Microdialysis, and Hugo Sachs Elektronik. Product portfolio encompasses electrophysiology systems (patch clamp amplifiers, multielectrode arrays, Ussing chambers), spectrophotometers and colorimeters (Ultrospec series, Biowave), amino acid analyzers, telemetry and behavioral monitoring systems, electroporation devices, and isolated organ perfusion systems. The company serves discovery, production, and regulatory compliance workflows for life-saving therapeutic development. Products include the INCUB8 multiwell MEA system for optical and electrophysiological recording, HEKA EPC 10 USB 3.0 patch clamp amplifier, IntraCell laser-based optoporation system, VivaMARS activity monitoring platform, Ponemah software (GLP and 21 CFR Part 11 compliant), continuous glucose telemetry for rodents, and various UV-Vis spectrophotometric instruments. The company actively participates in major scientific conferences including SfN, APS, ECS, and ISSCR, and maintains active engagement in neuroscience, cardiac, and translational research communities.

AgaMatrix is a diabetes management company specializing in blood glucose monitoring devices and related consumables for home use. The company manufactures digital glucose meters engineered for accuracy to support medication management, GLP-1 therapy monitoring, and continuous glucose monitor (CGM) confirmation. Their primary product lines include Presto (a simple, affordable glucose meter at $6.95) and Jazz Wireless 2 (a Bluetooth-enabled blood glucose meter with smartphone app integration at $14.95). AgaMatrix also distributes test strips, control solutions, and lancing devices with lancets. Products are designed for individual diabetes self-management and medication adherence. The company offers the AgaMatrix Diabetes Manager App for data tracking, glucose trend visualization, insulin unit monitoring, and dietary logging. Their devices target patients on insulin therapy and those using GLP-1 medications requiring frequent glucose monitoring. AgaMatrix positions itself as a value-oriented alternative in the home glucose monitoring market, emphasizing affordability, accuracy, and ease of use for everyday confidence in blood sugar management.

AmbiMedInc is a manufacturer of specialized injection aids and blood sampling devices designed for diabetes management and pain-reduction in clinical and home-care settings. The company produces a comprehensive product line including reusable lancing devices (ambi-Lancet®, EZ-Lance®), safety lancets (EZ-Lets™), syringe injection aids (Inject-Ease®), magnification aids (Insul-eze® syringe magnifiers), needle guides (Insul-Cap®), blood collection assistance devices (EZ-Vac®), injection pen needle concealment (HAN-Ease), insulin bottle holders (Ambi-Tray®), and insulated storage solutions (Insul-Tote®). Products address comfort, safety, and ease of use for subcutaneous injections and capillary blood sampling, with particular focus on anxiety reduction and accessibility for patients managing chronic conditions.

YASEE is a Chinese manufacturer of homecare and diagnostic medical devices founded in 2003. The company specializes in chronic disease monitoring and personal health management devices, including blood pressure monitors, blood glucose meters, pulse oximeters, infrared thermometers, oxygen concentrators, nebulizers, and disposable medical masks. The D7 Blood Pressure Monitor is a flagship product offering multiparameter testing (blood pressure, glucose, uric acid) with voice broadcast capability and dual-user memory. YASEE operates six production lines in a 100,000-level clean workshop facility. The company holds ISO 13485 certification and complies with YY0287-2017 quality management standards. YASEE provides OEM and white-label manufacturing services with 17 years of export trading experience, serving approximately 300 clients globally. The company accepts small orders with a minimum order quantity of 500 pieces and offers customized design and packaging services. Distribution occurs via DHL, UPS, FedEx, and TNT.

Medovate Limited is a UK-based medical device development and commercialization company specializing in bringing novel clinical innovations to market through structured partnerships with NHS clinicians and healthcare providers. The company operates across the full medical device development pipeline—from initial concept evaluation and clinical development through regulatory approval and global market launch. Medovate's current product portfolio includes Safira® (regional anesthesia injection safety system with automatic pressure limiting to reduce nerve injury risk), Glucosave® (critical care blood sampling safety device to prevent inappropriate insulin administration), Humidicare® (heat and moisture exchanger with visual alerts for mechanical ventilation circuits), LUMEVAC™ (endoscopic surgical device for management of life-threatening gastrointestinal tract infections), and CamPROBE (transperineal prostate biopsy facilitation device). The company leverages deep relationships with NHS institutions to validate medical needs, conduct clinical trials, and accelerate adoption of approved technologies. Medovate focuses on patient safety innovations and clinician-centered design, with demonstrated capability in securing regulatory clearance and driving market entry across multiple therapeutic domains including anesthesia, critical care, endoscopic surgery, and urology. The firm's model emphasizes unmet clinical needs resolution and cost-effective solutions for healthcare systems globally.

Contact Health Inc operates a cloud-based remote patient monitoring (RPM) and virtual care engagement platform designed for healthcare providers to remotely monitor and interact with diverse patient populations. The platform addresses chronic disease management, behavioral and physical therapy, post-discharge care programs, and senior/disabled populations. The company's integrated solution comprises three core components: the Contact Health Tablet (patient-facing device with two-way video, biometric data transmission, health education, medication/appointment reminders, and secure messaging); the Contact Health Portal (provider-facing command center with risk stratification, triage tracking, vital sign graphing, medication adherence monitoring, non-responder tracking, and outcome reporting); and Contact Health Vitals (an array of medical devices including weight scales, blood pressure cuffs, pulse oximeters, glucose meters, and spirometers for automated biometric capture). The platform enables providers to capture vital signs data, interpret alerts through automated triage logic, intervene via video consultations, and monitor patient compliance with care plans. Key features include data analytics and trend reporting, population work lists, care calendars, and logistics/program support services. The company markets the solution to healthcare systems, accountable care organizations, behavioral health providers, and post-acute care settings seeking to improve remote monitoring capabilities and reduce hospital readmissions. The address on file matches the website, and the company can be reached at the provided contact information.

UniStrip Technologies, LLC manufactures and distributes generic blood glucose test strips under the TruePoint and UNISTRIP brand names. The company specializes in glucose monitoring consumables designed as compatible alternatives to proprietary OneTouch test strips. TruePoint test strips utilize glucose oxidase technology and are compatible with multiple OneTouch meter models including Ultra, UltraMini, Ultra 2, and UltraSmart. The company markets its products as providing safer and more accurate results compared to branded alternatives. UniStrip serves the home diabetes management and personal medical device market, targeting patients and healthcare systems seeking cost-effective glucose monitoring supplies. Distribution channels include retail and direct-to-consumer purchase options. The company positions itself as a supplier of generic diabetes care consumables for the homecare market.

Metene Limited is a global homecare and personal medical device manufacturer specializing in blood glucose monitoring systems and vital signs monitoring devices. The company claims to be the world's No. 1 blood glucose monitor brand, with products sold in 58 countries and over 60 million units distributed worldwide. Metene's primary product line comprises blood glucose meters (TD-4116 and AGM-513S models), compatible test strips, and lancing devices designed for diabetics, elderly patients, pregnant women, and individuals at risk of diabetes. Key product features include rapid 5–7 second readings, minimal blood sample requirements (0.5–0.7 μL), no-coding convenience, data storage, and reminder alarms. The company also manufactures fingertip pulse oximeters (SpO2 monitors) and no-touch thermometers. Metene devices utilize advanced biosensor technologies including Glucose Dehydrogenase (FAD-GDH) enzymes and 99.99% gold electrodes to minimize interference and temperature/humidity deviation. Products are marketed as suitable for home and consumer use rather than clinical/hospital settings. The company operates a direct-to-consumer e-commerce platform (metene.com) with educational content on diabetes management and blood glucose monitoring. While the site emphasizes consumer accessibility and ease of use, specific regulatory certifications (FDA 510(k), CE marking, ISO 13485) are not explicitly mentioned in the fetched content. Manufacturing location and quality certifications remain undisclosed on the primary website.

Thirdwayv is an IoT connectivity and cybersecurity software company specializing in secure, connected medical devices and healthcare applications. The company provides end-to-end security solutions—from hardware root of trust through cloud infrastructure—for safety-critical IoT deployments in consumer medical devices, connected hospitals, home healthcare, electrical stimulation and drug delivery systems, and biometric monitoring. Core product lines include AppAuth™ (device and customer authentication, remote attestation), SecureConnectivity™ (application-layer encryption across Bluetooth, NFC, LTE, Ethernet), SeamlessConnect™ (seamless device-to-gateway connectivity), and RecordAuth™ (blockchain-based data authenticity for supply chains). Thirdwayv holds FDA clearances enabling partners to meet FDA cybersecurity guidelines for medical devices and has demonstrated expertise in connected diabetes management, pacemakers, nerve stimulators, defibrillators, insulin pumps, thermometers, blood pressure monitors, glucose meters, and pulse oximeters. The company also serves connected car (OTA firmware updates, infotainment security, smartphone keyless entry) and asset-tracking markets (cold chain, surgical implant track-and-trace, hospital inventory management, retail item tracking). Leadership includes executives from Motorola, Broadcom, and GE; the advisory board includes former Qualcomm, Google, BlackBerry, and FDA officials. Thirdwayv positions itself as a "nucleus of trust" for IoT ecosystems, emphasizing security-by-design from the semiconductor level upward.

Veridian Healthcare is a national distributor and supplier of healthcare diagnostics, home health, and connected patient monitoring devices founded in 2009. Based in the Chicago region with 50+ staff, the company specializes in: (1) Product Solutions—a broad catalog of house-branded and private-label home and healthcare professional products distributed through B2B retail partners, healthcare distributors, e-commerce platforms, and retailers; (2) Connected Care—the largest full-line of Bluetooth and cellular-enabled medical devices for remote patient monitoring, including blood pressure monitors, thermometers, pulse oximeters, scales, glucometers, fetal dopplers, activity trackers, and pill organizers. All connected devices are 510(k) registered and feature standardized SDKs for interoperability and integrated cellular services with pause/resume functionality. Veridian offers end-to-end solutions including product design, sourcing, importing, regulatory clearance, technology integration, private labeling, kitting, and logistics. The company serves health systems, RPM/telehealth providers, insurance companies, healthcare distributors, retailers (Amazon, CVS, Walgreens, Kroger, Dollar General, Publix), and e-commerce partners. House brands include HealthWise, RPM Pro, SmartHeart, TheraCare, Veridian, Zewa, Trackstar, and CoverGuard. Regulatory credentials include FDA 510(k) clearances for connected devices.

Senseonics, Inc. is a publicly traded medical device company headquartered in Germantown, Maryland, specializing in continuous glucose monitoring (CGM) systems for diabetes management. The company manufactures and markets the Eversense system, the first and only long-term implantable continuous glucose monitoring device. The Eversense CGM system features a subcutaneous glucose sensor designed for extended wear periods, including a 180-day implantable version and a next-generation 365-day implantable variant. The company's products are distributed through partnerships, including Ascensia Diabetes Care for select markets. Senseonics supports its systems with clinical evidence demonstrating improved glycemic control in CGM-naive patients, validated through clinical studies including the PROMISE and ENHANCE trials. The company maintains robust regulatory compliance with FDA clearance for its implantable glucose monitoring technology. Senseonics serves endocrinologists, diabetes educators, and hospital-based diabetes management programs across the United States and international markets, positioning itself as a leader in long-acting implantable CGM technology differentiated from traditional wearable glucose monitoring alternatives.

SiPhox Health is a Burlington, Massachusetts-based health diagnostics company specializing in silicon photonic biosensor technology for at-home blood testing and biomarker analysis. Founded in 2020 and backed by Y Combinator, Khosla Ventures, and Intel Capital, the company has delivered over 300,000 biomarker test results. SiPhox's proprietary EasyDraw kit enables painless upper-arm blood collection without needles or lab visits, with samples processed at CLIA-certified labs. The platform analyzes up to 60 biomarkers across cardiovascular, metabolic, hormonal, thyroid, liver, kidney, inflammation, and nutritional health. Beyond testing, SiPhox provides a centralized health dashboard with wearable integration (Apple Watch, Oura Ring, Fitbit), personalized supplement recommendations, lifestyle coaching, telehealth support, and an AI assistant (Sai) for result interpretation. The company targets chronic disease prevention and health optimization through evidence-based biomarker tracking and actionable insights.

Valmar Surgical Supplies is a home healthcare DME (durable medical equipment) distributor serving patients across the Northeast. Leveraging deep industry expertise and compassionate customer support, the company supplies mobility aids, respiratory therapy equipment, diabetic management supplies, and pressure ulcer prevention devices for home use. Valmar Surgical manages insurance authorizations, conducts clinical assessments to meet Medicare/payor requirements (WOPD, face-to-face exams), and provides next-day delivery. The company specializes in equipment selection counseling, ensuring patients receive products appropriate for their specific conditions and coverage eligibility. Services include detailed documentation support for enteral feeding, oxygen therapy, CPAP, orthotic and prosthetic devices, and post-operative support surfaces.

Diathrive, Inc. is an enterprise diabetes and metabolic health management platform serving organizations and employers. The company provides integrated solutions for diabetes care, continuous glucose monitoring (CGM), and GLP-1 weight management programs. Diathrive's service model combines unlimited medical supplies (lancets, testing devices), clinical support from registered nurses and certified diabetes care and education specialists (CDCES), and data-driven care coordination. The platform enables employers to optimize employee health outcomes while managing program costs through physician oversight, personalized support protocols, and ROI-focused monitoring. Services include Health Advisor support for scalable workforce wellness coaching, CGM cost control and utilization optimization, and comprehensive GLP-1 pharmacotherapy programs with clinical governance. The company targets large organizations seeking to reduce diabetes-related healthcare costs and improve employee productivity through evidence-based protocols and continuous remote monitoring.

Tianjin Empecs Medical Device Co., Ltd. is a Chinese manufacturer and supplier of blood glucose monitoring systems, acupuncture products, and diabetes care consumables. Founded in 1992 and formerly known as Tianjin Haing Lim Sou Won Medical Instrument Co., Ltd., the company has expanded from acupuncture needle manufacturing to biosensor technology for glucose monitoring. The company operates manufacturing facilities in Tianjin, China, and a Korea R&D center, with a U.S. branch established in 2003. Product portfolio includes no-coding and smart blood glucose meters (Medisign MM800, MM200, MM600, MM1000, MM1100, MM1200 series), blood glucose test strips (0.5µL sample volume), lancing devices, sterile and pre-loaded acupuncture needles, moxibustion products (sticks, blocks, pipes), and silicon cupping sets. The company holds FDA 510(k) clearance for blood glucose monitoring systems in the U.S. market, CE Mark certification in Europe, SFDA approval in China, and KFDA approval in Korea. Products are exported to Europe, America, Africa, and Asia. Manufacturing capacity of 5,000–10,000 square meters with 301–500 employees. The company markets products with an emphasis on affordable diabetes care and accessible pricing for patients in developing regions.

ForaCare Inc. is a healthcare technology company specializing in chronic disease management through integrated medical devices and telehealth software. The company designs and manufactures blood glucose monitors, blood pressure monitors, pulse oximeters, nebulizers, wireless weight scales, and Bluetooth thermometers for diabetes, hypertension, COPD, and chronic heart failure management. All devices connect via cellular or Bluetooth to the proprietary FORA® 24/7 HealthView Telehealth System, a HIPAA-compliant cloud platform that enables real-time remote patient monitoring and physician access to patient data. ForaCare also offers iFORA mobile applications available on iOS and Google Play for patient engagement and chronic disease self-management. The company manufactures and designs products with an emphasis on accuracy, ease of use, and clinical validation. Primary markets include remote patient monitoring programs for chronic disease management across diabetes care, hypertension management, respiratory care, and weight management. The FORA 24/7 HealthView System serves as the central integration hub connecting all wireless medical devices to a telehealth gateway for comprehensive remote monitoring. ForaCare operates with a global customer base and maintains design and manufacturing capabilities.

i-SENS is a global biotechnology company headquartered in South Korea and operating in over 110 countries, including the United States and Europe. The company is the market leader in Korea's blood glucose monitoring device market and specializes in blood glucose management systems, continuous glucose monitoring (CGM) systems, in vitro diagnostics (IVD), and veterinary diagnostic solutions. i-SENS manufactures the CareSens line of self-monitoring blood glucose systems, which meets ISO 15197:2013 accuracy standards for hematocrit and interference criteria. The CareSens Air continuous glucose monitoring system is the first domestically produced CGM in Korea with CE certification, providing real-time glucose data and trend analysis for diabetes management. The company's IVD System leverages whole blood-based diagnostic technology for point-of-care testing applications. i-SENS operates with an annual production capacity of 2.1 billion blood glucose test strips, supporting millions of patients globally. The company maintains regulatory compliance with FDA and CE certification standards. Recent partnerships include a transformational collaboration with LifeScan to launch the OneTouch® Continuous Glucose Monitoring System, leveraging i-SENS technology. The company serves healthcare systems, diabetes management clinics, point-of-care diagnostic facilities, and veterinary care providers. i-SENS is committed to advancing diabetes care innovation and expanding access to glucose monitoring solutions worldwide.